The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

Biosyent Inc down $0.16

Biosyent Inc closed sharply lower Monday, dropping $0.16 or 1.83% to $8.60. Over the last five days, shares have gained 1.90%, but are down 28.51% for the last year to date. Shares have outperformed the S&P TSX by 44.59% during the last year.

Key company metrics

  • Trailing P/E39.15×
  • P/E 1 year forward32.44×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.22
Updated April 20 3:59 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.34%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue3432
Total other revenue--------
Total revenue3432
Gross profit2322
Total cost of revenue1111
Total operating expense2222
Selling / general / administrative1111
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income1111
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1111
Income after tax1111
Income tax, total0000
Net income1111
Total adjustments to net income--------
Net income before extra. items1111
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1111
Inc. avail. to common incl. extra. items1111
Diluted net income1111
Dilution adjustment----00
Diluted weighted average shares14141414
Diluted EPS excluding extraordinary itemsvalue per share0.050.070.060.04
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.050.070.060.04